Glycine Treatment of Prodromal Symptoms

NCT00268749 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: glycine

Sponsor

Yale University

Collaborators

[object Object]